Nearly one-fifth of breast tumors have extra copies of the gene encoding one form of the estrogen receptor ESR1, suggests a study published online this week in Nature Genetics.
Only one per cent of women know that older women – those 80 or older – have the greatest risk of developing breast cancer according to new research published.
Variation in a genetic element that regulates the expression of the gene encoding caspase-8 (CASP8) is associated with differential susceptibility to several different cancers, according to a study to be published online this week in Nature Genetics.
Common cancers in NSW are predicted to change in the next 20 years to reflect cancers affecting our migrant population, according to a new report by The Cancer Council NSW.
Several newly identified genetic variants on chromosome 8 are associated with increased risk of developing prostate cancer, according to three studies to be published online this week in Nature Genetics.
Step-Up students from Corpus Christi College and Orangefield High School served up a feast at the Jordanstown campus to raise money for charity.
New scientific evidence is helping to build a compelling case for oncolytic viruses as a first-line and adjunctive treatment for many cancers. Reovirus, a non-pathogenic virus under development at Calgary, Alberta-based Oncolytics Biotech, has shown powerful anti-cancer activity against cultured tumor cells, in animal models, and in human clinical trials. Oncolytics’ proprietary reovirus formulation, Reolysin?, is active against numerous cancers, including intractable sarcomas and melanomas.
The Linda Lehrer Memorial Walk for Lung Cancer will be held at noon Saturday, May 19, at the Webster Thomas Field House. Webster Schroeder High School senior Allyssa Lehrer is organizing the event as a tribute to her aunt who died last fall and to fund lung cancer research at the James P. Wilmot Cancer Center.
Patients around the world face stark inequalities in access to cancer treatment, according to a report published today (Thursday 10 May) in the cancer journal, Annals of Oncology. The report’s authors urge decision makers in every country to take action and ensure that everyone has equal access to new cancer drugs when they are needed, wherever they live.
Hamilton College researchers have identified molecules that have been shown to be effective in the fight against breast cancer.